Purification is not only paramount for achieving a high purity, it is a major determinant for the productivity of the whole manufacturing process of APIs. That’s why the Berlin-based start-up Belyntic has taken a journey from an idea to improve peptide drug purification to founding a chemical company offering an innovative peptide manufacturing solution.

The idea was born within the circle of three friends that wanted to do something different at the end of their chemistry PhDs. The vision was that the new company should offer a chromatography-free peptide manufacturing solution. For that they invented the Peptide Easy Clean (PEC) technology. With this idea and together with a fourth founder, complementing the team with experience in business administration, the Belyntic story began.

See this webinar which will take you through this journey from how the idea sparked, through how Belyntic prepared for market entry and plan their future growth.

Chapters:
0:00 Webinar introduction
04:30 Introduction Belyntic
11:28 The beginning & idea of Belyntic
20:05 Testing the technology with Bachem
36:26 The pandemic as an opportunity
44:56 Questions & Answers

Speaker:
Robert Zitterbart, Ph.D.
Co-Founder, Head of R&D at Belyntic GmbH

Moderator:
Gavin Noble, Ph.D.
Process Optimisation Chemist at Bachem (UK) Ltd.
________________________________________________________________
About Bachem:

Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. With 50 years of experience and expertise Bachem provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services.

Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange. For further information, see www.bachem.com.

свернуть